Enveric BiosciencesSTU:SLZ0 30 FCF Yield % is -133.41 as of Jul. 02, 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,414 Biotechnology companies, Enveric Biosciences ranks worse than 93% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Enveric Biosciences FCF Yield % Related Terms
Enveric Biosciences FCF Yield % Historical Data
* Premium members only.
The historical data trend for Enveric Biosciences's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:SLZ0 vs APVO, CNSP, ADIL: FCF Yield % Comparison
For the Biotechnology subindustry, Enveric Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enveric Biosciences FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enveric Biosciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Enveric Biosciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences (STU:SLZ0) has a FCF Yield % of -133.41 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enveric Biosciences and its competitors. According to the industry distribution chart, Enveric Biosciences ranks #1315 out of 1414 companies in the Biotechnology industry, placing it in the top 93%.
Is Enveric Biosciences' FCF Yield % too high?
Enveric Biosciences' current FCF Yield % is -133.41. Based on the distribution chart, Enveric Biosciences ranks #1315 out of 1414 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enveric Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' FCF Yield % compare to APVO and CNSP?
According to the Biotechnology industry distribution chart, Enveric Biosciences ranks #1315 out of 1414 companies for FCF Yield %. This places Enveric Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current FCF Yield % is -133.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current FCF Yield % of -133.41. The current FCF Yield % is -133.41. Enveric Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current FCF Yield % is -133.41 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
30GF Score
Get the complete analysis for STU:SLZ0
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:SLZ0 has been successfully added to your 
